ReviewIranian journal of pharmaceutical research : IJPR2019
Review in Iranian journal of pharmaceutical research : IJPR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Advances in Research onMolecules (Basel, Switzerland) · 2026Review
- Refocusing the study of human-plant relations to the genus scale: Indigenous selection pressures in Xanthosoma.Journal of ethnobiology and ethnomedicine · 2026Article
- The Complete Mitochondrial Genome of theBiology · 2026Article
- Influence of yam-derived flours and fatty acids on the structural characteristics, physicochemical attributes, andFood chemistry: X · 2025Article
- Pan-genomic insights into RLK family evolution and adaptation in Dioscorea alata.Plant molecular biology · 2025Article
- Decoding natural products for neuroprotection: Pathway networks and structural insights for drug development.Chinese herbal medicines · 2025Review
- Bioactive Metabolites ofFoods (Basel, Switzerland) · 2025Review
- Modulation of the PI3K/Akt signaling pathway by resveratrol in cancer: molecular mechanisms and therapeutic opportunity.Discover oncology · 2025Review
- A critical review on phytochemicals as antiviral medications for SARS-CoV-2 virus infection.Naunyn-Schmiedeberg's archives of pharmacology · 2025Review
- Exploring the molecular mechanism ofHeliyon · 2025Article
- Genome-Wide Identification and Evolutionary Analysis of Receptor-like Kinase Family Genes Provides Insights into Anthracnose Resistance ofPlants (Basel, Switzerland) · 2024Article
- Isolation and identification of active ingredients and biological activity of Dioscorea nipponica Makino.BMC complementary medicine and therapies · 2023Article
- Review
- Development and Validation of Quantitative Analysis Method for Phenanthrenes in Peels of theJournal of microbiology and biotechnology · 2022Article
- Review
- Article
- Screening and Selection of a New Medium for Diosgenin Production via Microbial Biocatalysis ofPharmaceuticals (Basel, Switzerland) · 2021Article
- Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer.Cancer cell international · 2020Review
- Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen ofDrug design, development and therapy · 2020Article
- Antibacterial Activities ofFrontiers in pharmacology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.